New Ethiqa XR from Fidelis Pharmaceuticals is the first and only pharmaceutical grade extended-release buprenorphine proven effective in reducing pain for lab mice and rats up to 72 hours after administration of just one injection. See efficacy and safety.
Now Available though MWI Animal Health and Covetrus
Ethiqa XR will offer:
An Ethical Imperative
Effective pain management for laboratory animals is an essential need in today’s research. Learn more about industry association guidelines.
Want to learn more? Register for a webinar or to stay up-to-date on product availability.